Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) at last check was buoying at $15.01 on current market day with a fall of -2.08% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $15.33 and 5Y monthly beta was reading 0.386 with its price kept floating in the range of $14.99 and $15.22 on the day. Company’s P/E ratio for the trailing 12 months is 18.74. Considering stock’s 52-week price range provides that RDY hit a high price of $16.89 and saw its price falling to a low level of $12.26 during that period. Over a period of past 1-month, stock came adding 3.10% in its value.
With its current market valuation of $12.49 billion, Dr. Reddy’s Laboratories Ltd. ADR is set to declare its quarterly results on 2025-May-09. RDY Stock’s Forward Dividend of 0.10 and its yield of 0.63% are making investors’ thoughts stronger that it could climb further before the company announces its earnings for the current quarter.
In contrast, when we review RDY stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 50% Buy for it.
Digging deeper we become aware of the PEG ratio of the RDY stock which is currently positioned at 0. It further provides that stock’s current price level is -2.36% away from its 20-day simple moving average and is 3.14% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 48.10 while volatility remained at 1.58% over the past week which changes to 1.31% when measuring it over the past month. Beta is valued at 0.34.
Having a second look at Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) provides that stock’s average daily trading volume for 3 months was 2.05 million, while it jumped to 1656490 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 834.46 million.
The percentage of outstanding shares held by the insiders is 0.00% while it is 13.53% for the institutional holders. The figures also indicate that as of 2025-06-13, number of stock’s short shares was 12.47 million which implies a short ratio of 7.61. This shows down a 291.00 of Short Interest in company’s outstanding shares on the day. In June the standing of shares short improved as it was 14.93 million in the previous month. Addition of 4.52% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
